Regencell Bioscience (RGC) has had the highest return since January 1, 2025 by a mid-cap US stock, returning 12,482.3%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 12,482.34% |
QMMM Holdings Limited Ordinary Shares (QMMM) | 9,155.81% |
Abivax SA American Depositary Shares (ABVX) | 1,195.17% |
TMC the metals (TMC) | 679.39% |
Anbio Biotechnology Class A Ordinary Shares (NNNN) | 467.49% |
Centrus Energy (LEU) | 438.67% |
Opendoor Technologies (OPEN) | 365.85% |
Ramaco Resources (METC) | 364.43% |
Applied Digital (APLD) | 332.99% |
Cidara Therapeutics (CDTX) | 317% |
Energy Fuels (UUUU) | 287.43% |
GRAIL, LLC (GRAL) | 271.1% |
ViaSat (VSAT) | 270.68% |
Ondas (ONDS) | 268.8% |
Planet Labs PBC (PL) | 259.41% |
Cipher Mining (CIFR) | 250.62% |
Uniqure (QURE) | 244.85% |
Mineralys Therapeutics, Inc Common Stock (MLYS) | 241.93% |
Sandisk (SNDK) | 233.46% |
DRDGOLD Limited ADR (DRD) | 232.81% |
Sibanye Gold Ltd ADR (SBSW) | 221.11% |
SSR Mining (SSRM) | 218.75% |
American Bitcoin (ABTC) | 198.99% |
Metsera, Inc Common Stock (MTSR) | 193.72% |
NovaGold Resources (NG) | 188.69% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
